Jan Korbel | |
---|---|
Born | Chêne-Bougeries, Switzerland |
Nationality | German |
Scientific career | |
Fields | Human genetics & Computational biology |
Institutions | European Molecular Biology Laboratory (EMBL) |
Website | embl.de |
Jan O. Korbel (born 1975) is a German scientist working in the fields of human genetics, genomics and computational biology.
After receiving his PhD in 2005 from Humboldt University of Berlin, he pursued his postdoctoral research at Yale University, New Haven, Connecticut (USA). [1]
He is a tenured principal investigator and Heading the Data Science Centre at the European Molecular Biology Laboratory (EMBL) Heidelberg, Germany. He is also a senior scientist in the Genome Biology Unit at the EMBL, is leading a bridging research division at the German Cancer Research Center (DKFZ), and is a honorary professor ("Honorarprofessor") at Heidelberg University. A particular focus of the Korbel group is on investigating a particular form of mutation, genomic structural variation, which includes deletions, inversions and more complex chromosomal rearrangements such as chromothripsis events that can occur in healthy individuals and in context of disease. His group's principal research objective is to understand genomic structural variations as a basis of phenotypic variation and cancer development. [2]
In addition to his research activities, Jan Korbel is promoting interdisciplinary dialogues in bioethics, [3] and the application of genome sequencing in Genomic Medicine. [4]
He received several academic prizes, including:
He is an elected member of Germany's National Academy of Sciences Leopoldina [9] (2015) and of the European Molecular Biology Organization (EMBO) [10] (2016). He is also a fellow of the European Academy of Cancer Sciences. [11] Jan Korbel is also a European Research Council (ERC) investigator. [12]
Fotis Constantine Kafatos was a Greek biologist. Between 2007-2010 he was the founding president of the European Research Council (ERC). He chaired the ERC Scientific Council from 2006-2010. Thereafter, he was appointed Honorary President of the ERC.
John Frederick William Birney is joint director of EMBL's European Bioinformatics Institute (EMBL-EBI), in Hinxton, Cambridgeshire and deputy director general of the European Molecular Biology Laboratory (EMBL). He also serves as non-executive director of Genomics England, chair of the Global Alliance for Genomics and Health (GA4GH) and honorary professor of bioinformatics at the University of Cambridge. Birney has made significant contributions to genomics, through his development of innovative bioinformatics and computational biology tools. He previously served as an associate faculty member at the Wellcome Trust Sanger Institute.
Matthias Mann is a German physicist and biochemist. He is doing research in the area of mass spectrometry and proteomics.
Peter Becker is a German molecular biologist. He studied biology at the Ruprecht Karl University of Heidelberg until 1984 and finished his Ph.D at the German Cancer Research Center and the Ruprecht Karl University of Heidelberg in 1987. After being employed at the European Molecular Biology Laboratory (EMBL) from 1991 until 1999 he became head of the Adolf Butenandt Institute for molecular biology at the Ludwig Maximilian University of Munich. In 2000 he was elected as a member of EMBO.
Matthias Werner Hentze is a German scientist. He is the director of the European Molecular Biology Laboratory (EMBL), co-director of the Molecular Medicine Partnership Unit between EMBL and Heidelberg University, and Professor of Molecular Medicine at Heidelberg University.
Christos Louis, nicknamed Kitsos, is a Greek Molecular Geneticist. He graduated from the Medical School of the University of Marburg in 1974 and joined the team of Prof. C.E. Sekeris, first at Marburg and then at the German Cancer Research Center Heidelberg, obtaining his doctoral degree in Cell biology from Heidelberg University in 1977. His work focuses on Genomics and Bioinformatics of insects and vector-borne/tropical diseases.
Sarah Amalia Teichmann is a German scientist, the former head of cellular genetics at the Wellcome Sanger Institute and a visiting research group leader at the European Bioinformatics Institute (EMBL-EBI). She serves as director of research in the Cavendish Laboratory, Professor at the University of Cambridge and Cambridge Stem Cell Institute, and is a senior research fellow at Churchill College, Cambridge.
Andrea Ablasser is a German immunologist, who works as a full professor of Life Sciences at the École Polytechnique Fédérale de Lausanne. Her research has focused on how the innate immune system is able to recognise virus-infected cells and pathogens.
Rohini Kuner is an Indian-born German pharmacologist and director of the Institute of Pharmacology at Heidelberg University.
Elisa Izaurralde was an Uruguayan biochemist and molecular biologist. She served as Director and Scientific Member of the Department of Biochemistry at the Max Planck Institute for Developmental Biology in Tübingen from 2005 until her death in 2018. In 2008, she was awarded the Gottfried Wilhelm Leibniz Prize, shared with Elena Conti, for "fundamental new insights into intracellular RNA transport and RNA metabolism". Together with Conti, she helped characterize proteins important for exporting mRNA out of the nucleus and later in her career she helped elucidate mechanisms of mRNA silencing, translational repression, and mRNA decay.
Gregory James Hannon is a professor of molecular cancer biology and director of the Cancer Research UK Cambridge Institute at the University of Cambridge. He is a Fellow of Trinity College, Cambridge while also serving as a director of cancer genomics at the New York Genome Center and an adjunct professor at Cold Spring Harbor Laboratory.
Melina Schuh is a German biochemist and Director at the Max Planck Institute for Multidisciplinary Sciences. She is known for her work on meiosis in mammalian oocytes, for her studies on the mechanisms leading to the age-related decline in female fertility, and for the development of the Trim-Away protein depletion method.
Asifa Akhtar is a Pakistani biologist who has made significant contributions to the field of chromosome regulation. She is senior group leader and director of the Department of Chromatin Regulation at the Max Planck Institute of Immunobiology and Epigenetics. Akhtar was awarded EMBO membership in 2013. She became the first international and female vice president of the Max Planck Society's Biology and Medicine Section in July 2020.
Daniel Wolfram Gerlich is a German cell biologist. Since 2012 he has been a Senior Group Leader at the Institute of Molecular Biotechnology (IMBA) of the Austrian Academy of Sciences in Vienna.
Julius Brennecke is a German molecular biologist and geneticist. He is a Senior Group Leader at the Institute of Molecular Biotechnology. (IMBA) of the Austrian Academy of Sciences in Vienna.
Peter Scheiffele is a German neurobiologist who conducts research at the Biozentrum of the University of Basel, Switzerland.
Eileen E. M. Furlong is an Irish molecular biologist working in the fields of transcription, chromatin biology, developmental biology and genomics. She is known for her work in understanding how the genome is regulated, in particular to how developmental enhancers function, how they interact within three dimensional chromatin topologies and how they drive cell fate decisions during embryogenesis. She is Head of the Department of Genome Biology at the European Molecular Biology Laboratory (EMBL). Furlong was elected a member of the European Molecular Biology Organization (EMBO) in 2013, the Academia Europaea in 2016 and to EMBO’s research council in 2018.
Yardena Samuels or Samuels-Lev is an Israeli molecular biologist who is the Director of the Ekard Institute for Cancer Diagnosis Research at the Weizmann Institute of Science. Her research considers the genetic mutations of melanoma.
Nitzan Rosenfeld is a professor of Cancer Diagnostics at the University of Cambridge. He is a Senior Group Leader at the Cancer Research UK Cambridge Institute and co-founder of Inivata, a clinical cancer genomics company.
Stephan Beck FMedSci is a German-British geneticist and Professor of Medical Genomics at the University College London Cancer Institute.